Sunday, July 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Major Funds Increase Stakes in Barrick Gold Amid Strong Results

Rodolfo Hanigan by Rodolfo Hanigan
February 17, 2026
in Analysis, Commodities, Dividends, Earnings, Gold & Precious Metals
0
Barrick Mining Stock
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

Institutional confidence in Barrick Gold Corporation is mounting, as recent regulatory filings reveal significant new investments by heavyweight asset managers. This surge of institutional interest follows the gold producer’s announcement of robust quarterly earnings and a substantial dividend increase, even as a strategic move in North America introduces potential friction with a joint venture partner.

Robust Fundamentals Attract Capital

The financial elite’s growing appetite for Barrick shares is underpinned by solid operational performance. On February 5, the company released fourth-quarter 2025 results that surpassed market expectations. Revenue saw a year-over-year increase of nearly 45%, reaching $5.98 billion. Adjusted earnings per share came in at $1.04, exceeding consensus estimates. The company’s balance sheet remains strong, evidenced by a debt-to-equity ratio of just 0.13.

A major development for income-focused investors was the revised dividend policy. Concurrent with the earnings release, management declared a raise in the quarterly dividend payout from $0.18 to $0.42 per share. This annualizes to $1.68 per share, which, at a recent share price of $47.99, translates to a dividend yield of approximately 3.5%.

Notable Institutional Moves

Recent 13F filings with the U.S. Securities and Exchange Commission detail substantial portfolio adjustments favoring the mining giant.

Should investors sell immediately? Or is it worth buying Barrick Mining?

  • Mondrian Investment Partners established a new position in the third quarter, acquiring nearly 3 million shares. This stake holds a current market value of about $97.95 million.
  • CIBC Asset Management aggressively expanded its existing holding by 316%. The asset manager now controls a position worth over $600 million.

These moves place the London-based Mondrian alongside other prominent Barrick investors such as Vanguard and Arrowstreet Capital. Market data indicates that roughly 90.82% of Barrick’s outstanding shares are now held by institutional investors, signaling deep conviction in the company’s long-term direction.

Strategic IPO Plans and Partner Tensions

Beyond its operational strength, Barrick is advancing plans for a separate initial public offering (IPO) of its North American gold assets. This portfolio is expected to include the prestigious Nevada Gold Mines complex as well as projects in the Dominican Republic.

However, this strategic initiative faces a challenge. Joint venture partner Newmont Corporation has expressed concerns regarding operational performance in Nevada. The competitor has signaled its intention to review contractual protective clauses should the proposed separation structure impact existing agreements.

For shareholders, a key date is February 27. Investors registered by this record date will be eligible to receive the significantly increased dividend on March 16. While Barrick’s financial foundation appears healthy, the stock’s future trajectory may largely depend on management’s ability to navigate the tensions with Newmont and execute the planned North American IPO without delays.

Ad

Barrick Mining Stock: Buy or Sell?! New Barrick Mining Analysis from July 4 delivers the answer:

The latest Barrick Mining figures speak for themselves: Urgent action needed for Barrick Mining investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 4.

Barrick Mining: Buy or sell? Read more here...

Tags: Barrick Mining
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Bayer Stock
Analysis

Bayer’s Rally Faces a New Test: Antidumping Bid vs. Overbought Charts After Court Win

July 4, 2026
Antimony Resources Stock
Commodities

Antimony Resources: A Geopolitical Bet Gets a Geological Boost

July 4, 2026
Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

July 4, 2026
Next Post
Nvidia Stock

Nvidia Shares Face Critical Test as Investor Jitters Mount

Wendy's Stock

Wendy's Embarks on Major Restructuring Amid Domestic Sales Slump

Oracle Stock

Oracle's Strategic Pivot: Navigating Investor Skepticism Amid Major Shifts

Recommended

BioNTech Stock

Institutional Investors Double Down on BioNTech’s Strategic Pivot

4 months ago
Driven Brands Holdings Stock

Diverging Signals: Insider Selling Meets Analyst Confidence at Driven Brands

10 months ago
Polestar Auto.adr/a Stock

Polestar’s Financial Crisis Deepens Amidst Surging Sales

9 months ago
Gold Stock

Gold’s Year-End Rally Evaporates as Rate Cut Hopes Fade

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Digital Forklift Checklists and a Growing Cyber Threat: Inside Germany’s New Electrical Safety Rules

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

Trending

Bayer Stock
Analysis

Bayer’s Rally Faces a New Test: Antidumping Bid vs. Overbought Charts After Court Win

by Rodolfo Hanigan
July 4, 2026
0

Just five days after a landmark Supreme Court victory, Bayer has opened a second front in its...

Antimony Resources Stock

Antimony Resources: A Geopolitical Bet Gets a Geological Boost

July 4, 2026
ITM Power Stock

ITM Power: Inside the 113% Volatility Stock That Just Attracted a Government Stake and a Rheinmetall Pact

July 4, 2026
FALLBACK Stock

Digital Forklift Checklists and a Growing Cyber Threat: Inside Germany’s New Electrical Safety Rules

July 4, 2026
Outlook Therapeutics Stock

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

July 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bayer’s Rally Faces a New Test: Antidumping Bid vs. Overbought Charts After Court Win
  • Antimony Resources: A Geopolitical Bet Gets a Geological Boost
  • ITM Power: Inside the 113% Volatility Stock That Just Attracted a Government Stake and a Rheinmetall Pact

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com